John Bodensteiner (Consultant, Child and Adolescent Neurology), our Paediatric Neurology Section Editor for US Neurology, shares his expert perspective on Duchenne muscular dystrophy.
1. What do you consider the most promising current and emerging treatment options for Duchenne Muscular Dystrophy (DMD)? (0:11)
2. Could you tell us a little about the CINRG Duchenne Natural History Study? (0:34)
3. What were the findings of the CINRG study on the long-term effects of glucocorticoids in patients with DMD? (1:52)
4. On the basis of current evidence, what do you consider to be the optimal treatment regimen for children with DMD? (3:09)
Speaker disclosure: John Bodensteiner has nothing to disclose in relation to this video interview.
Filmed at the American Academy of Neurology (AAN) Annual Meeting 2018, Los Angeles, CA, US, April 2018.
Share this Video
Related Videos In Paediatric Neurology
Ingrid Scheffer, AES 2020 – Long Term Efficacy and Safety of Fenfluramine in Patients with Dravet Syndrome
We were delighted to talk to Ingrid Scheffer (The University of Melbourne, The Royal Children’s Hospital and Austin Health, Victoria, Australia) regarding the open-label extension study of fenfluramine in patients with Dravet syndrome (Clinical Trial Identifier: NCT02823145). The abstract ‘Efficacy and Tolerability of Adjunctive FINTEPLA (Fenfluramine Hydrochloride) in an Open-Label Extension Study of Dravet Syndrome […]
Kelly Knupp, AES 2020 – Fenfluramine for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome
We caught up with Kelly Knupp (University of Colorado, Anschutz Medical Campus, Children’s Hospital Colorado, CO, USA) to discuss the use of fenfluramine for the reduction of seizures associated with Lennox-Gastaut syndrome. (Clinical Trial Identifier: NCT03355209). The abstract ‘Efficacy and safety of FINTEPLA (fenfluramine) for the treatment of seizures associated with Lennox-Gastaut syndrome: a randomized, […]
DSUK – Dravet Syndrome in the COVID-19 Pandemic – Webinar with Professor Helen Cross OBE
Video produced by and shared with kind authorisation of Dravet Syndrome UK (DSUK). Professor Helen Cross OBE is a globally-recognised authority on Dravet Syndrome and Chair of DSUK’s Medical Advisory Board. On Monday 30 March, she took part in a webinar for families registered with DSUK, presenting on COVID-19 and answering a range of questions. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!